| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Departament de Fisiologia (M.D., J.V.P.), Facultat de Biologia, Universitat de Barcelona, 08028 Barcelona, Spain; Programme in Cell Biology (C.N.A., A.K.), The Hospital for Sick Children, Toronto, Ontario, Canada M5G 1X8; and Department of Pharmacological Sciences (E.C.), Stony Brook University, Stony Brook, New York 11794-8651
Address all correspondence and requests for reprints to: Dr. Josep V. Planas, Departament de Fisiologia, Facultat de Biologia, Universitat de Barcelona, 08028 Barcelona, Spain. E-mail: jplanas{at}ub.edu.
| Abstract |
|---|
|
|
|---|
| Introduction |
|---|
|
|
|---|
In our efforts to understand the role of GLUT4 in fish carbohydrate metabolism and its regulation by insulin, our group has identified, for the first time in nonmammalian vertebrates, two GLUT4-homologs in fish, one in brown trout skeletal muscle (btGLUT4) and another one in salmon adipose tissue (okGLUT4) (4, 5). Kinetic studies of okGLUT4 expressed in Xenopus oocytes have shown that it is a selective glucose transporter but with lower affinity than mammalian GLUT4 (4). This difference in affinity may explain the well-known lower ability of fish to clear a glucose load, when compared with mammals (6, 7). However, additional properties of the transporter traffic may contribute to this effect. We have shown that insulin is able to cause the translocation of okGLUT4 to the plasma membrane when transiently expressed in 3T3-L1 adipocytes, a response that may underlie the effect of insulin enhancing glucose uptake in isolated trout adipocytes (4).
In fish, skeletal muscle is the major site for glucose uptake because it represents more than 50% of the body weight (6). Unfortunately, the role of insulin on glucose transport in fish skeletal muscle is poorly understood. We previously demonstrated that blood insulin levels may regulate btGLUT4 expression in skeletal muscle (8, 9), probably by a direct action of insulin on trout skeletal muscle cells regulating the expression of the btGLUT4 gene (Díaz, M., and J. Planas, unpublished observations). However, we do not know whether btGLUT4 traffic in muscle cells is regulated by insulin. To characterize the regulation of btGLUT4 translocation in muscle cells and directly compare it with that of the mammalian GLUT4, we generated an L6 cell line that stably overexpresses btGLUT4 harboring an exofacial myc epitope (btGLUT4myc). These cells are thus a useful comparative to the well-characterized L6 cell line stably expressing rat-GLUT4myc (10, 11). Our results indicate that btGLUT4myc translocates to the cell surface of L6 cells in response to insulin but that its steady-state level at the cell surface under basal conditions is higher, compared with rat-GLUT4myc. This difference is caused by a faster externalization rate and not by a slower endocytic rate of btGLUT4myc. In addition, the intracellular distribution of btGLUT4myc in L6 myoblasts as well as endogenous btGLUT4 in trout muscle cells is diffuse throughout the cytoplasm and not concentrated in the perinuclear region. We suggest that the difference in traffic between fish and mammalian GLUT4 could be related to differences in the sequence of certain protein motifs that may result in a different interaction between fish GLUT4 and GLUT4-interacting proteins. Therefore, understanding the traffic characteristics of fish GLUT4, which could be considered a natural mutant of mammalian GLUT4, could be important for unraveling the mechanisms responsible for the intracellular retention of GLUT4 in mammalian cells.
| Materials and Methods |
|---|
|
|
|---|
-MEM and fetal bovine serum (FBS) were from Invitrogen (Prat del Llobregat, Spain). DMEM and all other tissue culture reagents were purchased from Sigma (Tres Cantos, Madrid, Spain). Plasticware for cell culture was from BD Biosciences (Madrid, Spain). The Effectene transfection reagent was from QIAGEN (Hilden, Germany). Human insulin (Humulin R) was from Lilly (Alcobendas, Madrid, Spain). Salmon insulin was kindly supplied by Dr. E. M. Plisetskaya (University of Washington, Seattle, WA). Cationic silica was a kind gift of Dr. David E. James (Garvan Institute of Medical Research, Sydney, Australia). Indinavir was kindly provided by Merck (Haarlem, The Netherlands). Monoclonal and polyclonal anti-myc antibodies were purchased from Santa Cruz Biotechnology (Santa Cruz, CA). Polyclonal anti-GLUT1 antibody was obtained from Abcam (Cambridge, UK) and kindly donated by Dr. Antonio Zorzano (Universitat de Barcelona, Barcelona, Spain). Horseradish peroxidase (HRP)-conjugated goat antirabbit IgG was from Jackson ImmunoResearch (Soham, UK). AlexaFluor488-conjugated goat antirabbit IgG was obtained from Invitrogen. Immunofluore mounting medium was from ICN Biochemicals (Madrid, Spain). 2-Deoxy-D-[2,6-3H]glucose (2-DG) was purchased from Amersham Biosciences (Barcelona, Spain). Bio-Rad protein assay was obtained from Bio-Rad (Prat del Llobregat, Spain).
Construction of c-myc epitope-tagged btGLUT4 cDNA expression vector
The cDNA sequence of human c-myc epitope (5'-GCAGAGGAGCAAAAGCTTATTTCTGAAGAGGACTTGCTTAAG-3') was introduced into the cDNA coding sequence of btGLUT4 (AF247395) (5), between Gly58 and Glu59, in the region corresponding to the first extracellular loop of btGLUT4 protein. This insertion was carried out by the overlapping PCR method. Two rounds of PCR were necessary to obtain the final construct. In the first round, two DNA fragments were obtained separately: one fragment corresponding to the btGLUT4 cDNA sequence coding for the amino acids 1–58 and carrying the cDNA sequence of c-myc epitope at the 3' end and another DNA fragment corresponding to the btGLUT4 cDNA sequence coding for the amino acids 59–503 and carrying the c-myc sequence at the 5' end. At the second round of PCR, these two initial fragments were used as templates to obtain the cDNA coding sequence of btGLUT4 with the inserted myc sequence (btGLUT4myc). Finally btGLUT4myc was subcloned into the mammalian expression vector pCXN2 (12).
Generation of L6-btGLUT4myc stable cell line
Parental L6 myoblasts were cotransfected with the expression vector pCXN2-btGLUT4myc and the pSV2-bsr plasmid (a blasticidin S deaminase expression plasmid) using the Effectene transfection reagent (QIAGEN). Transfected cells were selected with blasticidin S hydrochloride. Fifteen clones were isolated and their btGLUT4myc expression was analyzed by immunoprecipitation and subsequent immunoblotting against the myc epitope. The ability of each clone to fuse and form myotubes was also monitored.
L6 cell culture
L6 myoblasts were maintained with
-MEM containing 10% FBS and 1% antibiotic-antimycotic solution (10,000 U/ml penicillin G, 10 mg/ml streptomycin, 25 µg/ml amphotericin B) in an atmosphere of 5% CO2 at 37 C. For GLUT4myc-expressing L6 cells, the medium was also supplemented with 2 µg/ml blasticidin hydrochloride. To induce differentiation of myoblasts into myotubes, the percentage of FBS in the medium was reduced to 2%.
Isolation of muscle cells from brown trout (Salmo trutta)
Brown trout of 5–10 g body weight were obtained from the Piscifactoria de Bagà (Barcelona, Spain) and were maintained in the facilities of the Faculty of Biology at the University of Barcelona in a closed-water flow circuit with water at a temperature of 12 C. Animals (40–80 for each isolation) were killed by a blow to the head and immersed in 70% ethanol for 30 sec to sterilize external surfaces. Muscle cells were isolated and cultured following a protocol described by Castillo et al. (13) and Fauconneau and Paboeuf (14). Cells were cultured on six-well plates for plasma membrane preparation or 12-well plates for glucose uptake assay at a density of 3–4 x 106 and 1 x 106 cells/well, respectively. Plates were previously treated with poly-L-lysine and laminin to facilitate muscle cell adhesion. After 24 h of plating, plates were washed to eliminate nonadherent cells to the well. Cells were maintained at 18 C with DMEM containing 9 mM NaHCO3, 20 mM HEPES, 10% FBS and antibiotic-antimycotic cocktail (100 U/ml penicillin, 100 µg/ml streptomycin, 250 ng/ml amphotericin B). All cultures were monitored by observation under an inverted microscope. The experimental protocols used for trout in this study have been reviewed and approved by the Ethics and Animal Welfare Committee of the University of Barcelona, Spain.
Determination of the proportion of GLUT4myc at the cell surface
L6 myoblasts were serum deprived for 3–5 h and subsequently stimulated, or not, with 100 nM insulin for 20 min. Medium was then removed by repeated washing in ice-cold PBS (154 mM NaCl, 5.6 mM Na2HPO4, 1.1 mM KH2PO4) supplemented with 1 mM CaCl2 and 1 mM MgCl2 at 4 C [PBS+ (pH 7.4)]. To label cell surface GLUT4myc in intact L6 myoblasts, cells were blocked in 5% goat serum (GS) in PBS+ for 15 min and then incubated with
-myc antibody solution (1.0 µg/ml in PBS+ with 5% GS) for 1 h at 4 C. After labeling, excess
-myc antibodies were removed by extensive washing in ice-cold PBS+. Cells were then fixed in 4% paraformaldehyde (PFA) in PBS+ for 30 min and quenched in 100 mM glycine in PBS+ for 10 min, all at 4 C. To label total cellular GLUT4myc, a separate set of L6 cells were first fixed in 4% PFA in PBS+ for 30 min, quenched in 100 mM glycine in PBS+ for 10 min, and then permeabilized in 0.1% Triton X-100 for 30 min, all at 4 C. After blocking in 5% GS in PBS+ for 15 min, total cellular GLUT4 was labeled by incubation with
-myc antibody solution (1.0 µg/ml in PBS+ with 5% GS) for 1 h at 4 C, after which excess antibodies were removed by extensive washing in ice-cold PBS+. Both cell surface or total cellular GLUT4-bound anti-myc antibodies were probed by HRP-conjugated secondary antibodies followed by detection of bound HRP by o-phenylenediamide (OPD) assay, as previously described (15). The fraction of GLUT4myc at the cell surface, measured in triplicate, was taken as the ratio of surface GLUT4myc to total cellular GLUT4myc.
Glucose uptake measurements
Determination of 2-DG uptake in L6 cells was performed as described by Huang et al. (16) with some modifications. Glucose uptake was assessed for 5 min in HEPES-buffered saline [140 mM NaCl, 20 mM HEPES, 5 mM KCl, 2.5 mM MgSO4, 1 mM CaCl2 (pH 7.4)] containing 10 µM 2-DG (0.5 µCi/ml 2-[3H]DG) at room temperature. Subsequently, cells were rinsed three times with an ice-cold solution containing 0.9% NaCl and 20 mM D-glucose. To quantify the radioactivity incorporated by the cell, cells were lysed with 0.05 N NaOH, and lysates were counted with scintillation liquid in a β-counter. Nonspecific uptake was carried out in the presence of cytochalasin B (20–50 µM) during the assay, and these values were subtracted from all other values. Total protein content was measured with the Bio-Rad protein assay.
In trout muscle cells, glucose uptake assay was performed as follows. After 5 d in culture, trout muscle cells were serum starved for 4 h and subsequently incubated in the absence or presence of 1 µM salmon insulin for 30 min at 18 C. Cells were washed twice with PBS and incubated with HEPES-buffered saline containing 50 µM 2-DG (2 µCi/ml 2-[3H]DG) for 30 min at 18 C. After this period, transport solution was removed and cells were rinsed three times with ice-cold PBS containing 50 mM glucose. Finally, cells were lysed with 0.1 N NaOH and 0.1% sodium dodecyl sulfate, and radioactivity was determined by scintillation counting. Protein concentration was measured with the Bio-Rad protein assay. Nonspecific uptake was carried out in the presence of 10 µM cytochalasin B in the transport solution, and these values were subtracted of all other values.
GLUT4myc internalization assay
L6 myoblasts were serum deprived for 3–5 h and then washed in ice-cold PBS+. To label cell surface GLUT4myc in intact L6 myoblasts, cells were blocked in 5% GS in PBS+ for 15 min and then incubated with
-myc antibody solution (1.0 µg/ml in PBS+ with 5% GS) for 1 h at 4 C. The cells were then washed extensively in ice-cold PBS+, twice in 37 C PBS+ (rewarming stage), and subsequently returned to 37 C
-MEM for 0, 2, 5, or 10 min, as indicated (internalization stage). After internalization of surface proteins, L6 cells were rapidly washed in ice-cold PBS+ to arrest membrane traffic, fixed in 4% PFA in PBS+ for 10 min, and quenched by 100 mM glycine in PBS+ for 10 min, all at 4 C. GLUT4-bound anti-myc antibodies remaining at the cell surface were probed by HRP-conjugated secondary antibodies followed by detection of bound HRP by OPD assay, as previously described (15). The amount of GLUT4myc remaining at the cell surface after various times of internalization, measured in triplicate, was expressed as the fraction of GLUT4 at the cell surface before internalization.
GLUT4myc recycling assay
L6 myoblasts were serum deprived for 3 h and then incubated with 1.0 µg/ml
-myc antibody (in
-MEM) for 50, 100, 200, 300, or 400 min at 37 C to label the GLUT4 recycling through the plasma membrane (PM) during the indicated time. Subsequently, L6 myoblasts were extensively washed in ice-cold PBS+ to remove excess antibodies and then fixed in 4% PFA in PBS+ for 30 min and quenched in 100 mM glycine in PBS+ for 10 min, all at 4 C. After blocking in 5% GS in PBS+ for 15 min, GLUT4-bound anti-myc antibodies were probed by HRP-conjugated secondary antibodies followed by detection of bound HRP by OPD assay, as previously described (15). The total cellular amount of GLUT4myc was determined in permeabilized cells as described above. The amount of GLUT4myc having recycled through the PM, measured in triplicate, was expressed as a ratio of total cellular GLUT4myc.
Immunofluorescence microscopy
Twenty-four hours after seeding on glass coverslips, L6 myoblasts stably expressing either fish- or rat-GLUT4myc (15) were transfected by Lipofectamine 2000 (Invitrogen, Carlsbad, CA), as described by the manufacturer, with cDNA encoding hemagglutinin (HA) epitope-tagged rat-GLUT4 (rat-GLUT4-HA). Twenty-four hours after transfection, L6 myoblasts were serum deprived for 3–5 h, washed extensively with ice-cold PBS+, fixed for 30 min in 4% PFA in PBS+, quenched in 100 mM glycine in PBS+ for 10 min, and then permeabilized in 0.1% Triton X-100 in PBS+ for 30 min, all at 4 C. L6 myoblasts were then blocked in 5% GS for 15 min and incubated with both polyclonal
-myc and monoclonal
-HA antibodies for 1 h at 4 C. For colocalization studies of GLUT4myc and GLUT1, L6 myoblasts were incubated with a monoclonal anti-myc antibody and a polyclonal antibody against the C terminus of GLUT1. After removal of excess antibodies by extensive washing in ice-cold PBS+, cells were incubated with appropriate fluorophore-conjugated secondary antibodies. After removal of excess secondary antibodies by washing in PBS+, coverslips were then mounted in Dako on glass slides.
To perform immunofluorescence analysis in brown trout muscle cells, these were grown on glass coverslips previously coated with poly-L-lysine and laminin. Cells were rinsed with PBS and fixed with 3% PFA in PBS for 15 min at room temperature. After washing three times, cells were sequentially incubated with 100 mM glycine in PBS for 10 min and permeabilized with 0.1% saponin in PBS for 20 min. All the subsequent incubations and washes were made in the presence of 0.1% saponin. Cells were blocked with 10% GS for 20 min and subsequently incubated with the primary antibody against okGLUT4 (4) diluted 1:50 in blocking solution for 1 h at room temperature. After several washes with 0.1% saponin in PBS, cells were incubated with AlexaFluor488-conjugated secondary antibody for 1 h at room temperature. Coverslips were washed and mounted with Immunofluore mounting medium. Confocal images were obtained with a SPII laser confocal fluorescence microscope (Leica, Heidelberg, Germany) with a x63 objective.
Plasma membrane isolation
Plasma membrane preparations were obtained as described by Chaney and Jacobson (17) and Larance et al. (18). Trout muscle cells at d 5 of culture were serum deprived for 4 h and incubated in the absence or presence of 1 µM salmon insulin at 18 C for 30 min. After washing the cells with ice-cold PBS, cells were rinsed twice with ice-cold coating buffer [20 mM MES, 150 mM NaCl, 280 mM sorbitol (pH 5.0–5.5)] and cationic silica 1% in coating buffer was added to the cells for 2 min at 4 C. The excess of silica was removed and cells were washed with ice-cold coating buffer. After incubation with 1 mg/ml polyacrylic acid for 2 min at 4 C, cells were washed with coating buffer and lysed with modified HES buffer [20 mM HEPES, 250 mM sucrose, 1 mM dithiothreitol, 1 mM magnesium acetate, 100 mM potassium acetate, 0.5 mM zinc chloride (pH 7.4)]. The lysate was passed 12 times through a 22-gauge needle and 6 times through a 27-gauge needle. One volume of nycodenz (100% in modified HES buffer) was added to the lysate that was layered onto 0.5 ml 70% nycodenz and centrifuged in a swing-out rotor at 41,545 x g for 20 min at 4 C. The pellet was resuspended in modified HES buffer and spun at 500 x g for 5 min at 4 C three times to remove all nycodenz. The final pellet was resuspended in Laemmli sample buffer, heated at 65 C for 10 min, and centrifuged at 10,000 x g for 5 min. The resulting supernatant was stored at –80 C until immunoblot analysis.
Electrophoresis and immunoblotting
Plasma membrane samples (4 µg protein) were subjected to 12% SDS-PAGE and proteins were transferred to a polyvinylidene difluoride membrane. The membrane was blocked with blocking buffer (Tris-buffered saline containing 0.1% Tween 20 and 5% nonfat dry milk) for 2 h and subsequently incubated overnight with a polyclonal anti-okGLUT4 antibody diluted to 1:500 in blocking buffer at 4 C. After several washes, the membrane was incubated with HRP-conjugated secondary antibody for 1 h at room temperature. Immunoreactive bands were visualized by chemiluminescence and quantified with an image analyzer (version 1.11; TotalLab, Nonlinear Dynamics, Newcastle upon Tyne, UK).
Statistical analysis
Values are given as mean ± SE. Analysis of statistical significance of differences in measurements between samples was done by one-way ANOVA with Newman-Keuls posttest and Students t test.
| Results |
|---|
|
|
|---|
|
Insulin stimulates glucose uptake in L6-btGLUT4myc cells
Glucose uptake measurements in the L6-btGLUT4myc cell line were conducted to assess the effect of btGLUT4myc overexpression in L6 cells at the myoblast and myotube stages. After 3–5 h of serum starvation, cells were incubated with different concentrations of insulin (0, 10, and 100 nM) for 20 min followed by the glucose uptake assay. In parallel, the same experiments were also performed in wild-type L6 cells (untransfected cells) and L6-ratGLUT4myc cells. In myoblasts, L6-btGLUT4myc cells together with wild-type L6 cells and L6-ratGLUT4myc cells showed insulin-stimulated glucose uptake (Fig. 2
). In all three cell lines, insulin already increased glucose uptake at 10 nM, and in wild-type and rat-GLUT4myc-expressing myoblasts, this stimulation was slightly higher at 100 nM. In myotubes, insulin also significantly stimulated glucose uptake in all three cell lines (data not shown). Similar results were obtained with clones 7 and 9 at both myoblast and myotube stages (data not shown). L6-btGLUT4myc myoblasts exhibited a basal glucose uptake rate 2.1-fold higher than that of wild-type cells (10.86 ± 0.78 vs. 5.21 ± 0.67 pmol 2-DG mg–1/min–1, respectively), whereas the glucose uptake rate of L6-ratGLUT4myc myoblasts under basal conditions was 3.8-fold higher than that of L6 wild-type cells (19.83 ± 1.49 vs. 5.21 ± 0.67 pmol 2-DG mg–1/min–1, respectively). The lower basal glucose uptake rate of L6-btGLUT4myc myoblasts, compared with L6-ratGLUT4myc cells, could be attributed, in part, to the lower affinity for glucose described for fish GLUT4 (4) and/or possible differences in activity of the transporter because the expression levels of btGLUT4myc and rat-GLUT4myc in the L6 lines appear to be similar (Fig. 1Ai
).
|
|
-MEM with anti-myc antibody during different times to label any GLUT4myc molecule arriving at the plasma membrane. After this period the amount of labeled GLUT4myc at the plasma membrane was quantified and referred to the total amount of GLUT4myc. At 200 and 300 min, a greater amount of btGLUT4myc had reached the cell surface, compared with rat-GLUT4myc (Fig. 4B
|
|
|
|
| Discussion |
|---|
|
|
|---|
Steady-state distribution of btGLUT4
To carry out a direct comparison between the traffic of btGLUT4 and that of its rat homolog, we expressed both transporters in the same L6 cell background, a rat muscle cell line that has been well characterized in terms of insulin response and glucose transport regulation (10, 25, 26, 27). Generation of a stable L6 cell line expressing the myc-tagged rat-GLUT4 has provided a useful tool to study the intracellular traffic of GLUT4 and its regulation by insulin in mammalian skeletal muscle cells (10, 11, 15). Thus, we generated a stable L6 cell line overexpressing myc-tagged btGLUT4 (L6-btGLUT4myc). Tagging GLUT4 protein in an exofacial domain (loop between transmembrane domains 1 and 2) with the myc epitope allows measuring the amount of transporter inserted at the plasma membrane in intact cells by an easy and highly sensitive method (15) and also allows discerning the endogenous GLUT4 from the exogenously expressed GLUT4. Steady-state levels of btGLUT4myc and rat-GLUT4myc, used as a control, at the cell surface were examined in response to insulin. Our results indicate that insulin stimulates the translocation of btGLUT4myc to the plasma membrane in a manner similar to rat-GLUT4myc, as previously described (16, 28). Furthermore, the increase in the amount of GLUT4myc at the cell surface in response to insulin led to an enhanced glucose uptake activity in L6-btGLUT4myc and L6-ratGLUT4myc cells at the myoblast and myotube stages. The observed effects of insulin increasing glucose uptake in L6-ratGLUT4myc cells agree with previous reports (11, 29).
To confirm that insulin-stimulated translocation of btGLUT4 occurs in fish cells, we investigated the effects of insulin on btGLUT4 translocation in primary brown trout skeletal muscle cells. Immunoblotting analysis of purified plasma membranes revealed that insulin increases the amount of endogenous GLUT4 at the plasma membrane of brown trout muscle cells, resulting in an improved ability of these cells to take up glucose as shown by the increase in the glucose uptake rate in insulin-treated cells. The stimulation of glucose transport by insulin in brown trout skeletal muscle cells is in agreement with previous studies using primary cultures of muscle satellite cells from rainbow trout (30), chicken (31), sheep (32), and humans (33, 34). Taken together, these findings represent the first demonstration that insulin is able to cause the translocation of fish GLUT4 in muscle cells. We previously described the translocation of okGLUT4 (a GLUT4-homolog in salmon) to the plasma membrane in response to insulin when expressed in 3T3-L1 adipocytes (4). Furthermore, this is the first report describing the insulin-regulated translocation of endogenous GLUT4 in fish cells. Therefore, fish GLUT4, like mammalian GLUT4, is regulated by insulin in terms of its translocation to the plasma membrane.
Endocytosis and recycling of btGLUT4
Although btGLUT4myc, as rat-GLUT4myc, was recruited to the plasma membrane in response to insulin in L6 cells, the steady-state level of btGLUT4myc at the cell surface under basal conditions was higher than that of rat-GLUT4myc. A similar observation was reported by Capilla et al. (4) in 3T3-L1 adipocytes transiently expressing okGLUT4, which also showed higher levels of transporter at the plasma membrane in the basal state than those expressing rat-GLUT4. Therefore, given the difference between btGLUT4 and rat-GLUT4 in protein motifs known to be important for GLUT4 trafficking, we hypothesized that the higher steady-state level of btGLUT4myc at the plasma membrane could be the result of different traffic mechanisms between fish and mammalian GLUT4. In mammalian muscle and adipose cells, GLUT4 is known to be continuously cycling between the plasma membrane and intracellular compartments (35). Thus, the amount of GLUT4 localized at the cell surface is a dynamic pool that depends on its exocytosis to the plasma membrane and its internalization to intracellular vesicles (36). Our results support the hypothesis that both transporters have a similar internalization rate, although btGLUT4myc reaches the plasma membrane (i.e. externalizes) more quickly than its mammalian counterpart. Therefore, because btGLUT4myc endocytosis does not differ from that of rat-GLUT4myc, the higher percentage of btGLUT4myc at the cell surface under basal conditions may only be explained by a faster recycling of the transporter to the plasma membrane.
Subcellular distribution of btGLUT4
After biosynthesis, GLUT4 is targeted from the trans-Golgi network (TGN) to specific membrane compartments that are insulin-responsive and referred to as the GLUT4 storage compartment (GSC) (37). Thus, these results suggest that a fraction of btGLUT4 could exit the exocytic route from the TGN to the GSC and instead follow directly from the TGN to the plasma membrane, like GLUT1 (37). Our observation that btGLUT4myc has a diffuse cytoplasmic distribution ecchoing than that of GLUT1 (38) would support this idea. However, it is also possible that btGLUT4 could reach the GSC but that it may not be efficiently retained and consequently travels to the plasma membrane. Interestingly, transient transfection of rat-GLUT4-HA in L6-btGLUT4myc myoblasts showed that in unstimulated cells btGLUT4myc does not completely colocalize with HA-tagged rat-GLUT4, exhibiting a more diffuse distribution throughout the cytoplasm. Conversely, rat-GLUT4myc showed a complete colocalization with transfected rat-GLUT4-HA in the perinuclear region. In support of our observations on L6-btGLUT4myc myoblasts, immunolocalization studies in primary brown trout muscle cells also demonstrated a diffuse distribution of btGLUT4 throughout the cytoplasm, although in fully differentiated myotubes, certain accumulation of btGLUT4 was observed in the perinuclear region. Therefore, our immunofluorescence experiments indicate that btGLUT4 has a different subcellular localization than rat-GLUT4 in muscle cells. Overall, our data suggest that btGLUT4 and rat-GLUT4 differ in their intracellular traffic mechanisms.
Possible mechanisms governing traffic of btGLUT4 and rat-GLUT4
It is tempting to speculate that the differences between btGLUT4 and rat-GLUT4 in terms of the sequence of particular protein motifs known to be important for GLUT4 traffic in mammalian cells could affect the interaction of btGLUT4 with regulatory proteins involved in the proper sorting and targeting of mammalian GLUT4. The dileucine motif at the carboxyl-cytoplasmic tail of mammalian GLUT4 has been described as crucial for its internalization from the plasma membrane as well as for its intracellular retention (19, 24, 39, 40). Interestingly, these two leucines at positions 489 and 490 are missing in the btGLUT4 sequence (5), arguing against an important role of this motif in GLUT4 internalization. Moreover, the dileucine motif has also been involved in GLUT4 targeting from the TGN to the GSC (21, 23). Furthermore, btGLUT4 also lacks two arginine residues located at positions –4 and –5 upstream from the dileucine signal that have been implicated along with the dileucine motif in the intracellular sorting and endocytosis of mammalian GLUT4 (23). On the other hand, some authors have pointed to the importance of the amino-terminal FQQI motif in the intracellular localization of GLUT4 (20, 22, 41, 42, 43). In the btGLUT4 sequence, this motif is partially conserved (FQHL) but still contains the phenylalanine residue that appears to be essential for a proper GLUT4 sorting (42). Taking these sequence motif comparisons together with the fact that btGLUT4 presented the same internalization rate as rat-GLUT4, our data seem to support the notion that the FQQI motif is a major regulator of GLUT4 endocytosis. Therefore, btGLUT4 can be considered a natural mutant of GLUT4 that could assist in understanding the role of GLUT4 protein motifs in cellular traffic.
In addition to the structural GLUT4 motifs, several proteins have been shown to be important for mammalian GLUT4 traffic. Williams et al. (44) recently described that golgin-160, a protein localized to the Golgi cisternae, is required for the sorting of GLUT4 to the GSC, specifically for appropriate TGN sorting. As mentioned above, newly synthesized GLUT4 traffics from the TGN to GSC, and this sorting step is dependent on the GGA (Golgi localized,
-ear containing, Arf binding protein) adaptor complex (37, 45). In addition, the Rab GTPase activating protein AS160 (Akt substrate of 160 kDa) contributes to the basal intracellular retention of GLUT4 (18, 46). This protein is associated with GLUT4 vesicles in the basal state and dissociates in response to insulin, allowing GLUT4 vesicles to travel to the plasma membrane. In myoblasts, this protein exerts its action via Rab proteins, particularly Rab8A and Rab14 (47). Neither golgin nor AS160 appears to interact directly with GLUT4. In contrast, TUG (tether, containing a UBX domain, for GLUT4) (48) interacts with the large cytosolic loop of GLUT4 forming a complex localized in the GSC, and upon insulin stimulation, this complex disassembles, allowing GLUT4 translocation to the plasma membrane. Recent studies have shown that disruption of TUG function leads to a redistribution of GLUT4 to the cell surface in the basal state (49). Other proteins such as
-actinin-4 and aldolase have been shown to link GLUT4 to the actin cytoskeleton (50, 51). In particular,
-actinin-4 coimmunoprecipitates with GLUT4 in L6 muscle cells in an insulin-dependent fashion (50). Therefore, the difference in traffic between fish and mammalian GLUT4 could be related to differences in their ability to interact with these and other proteins involved in the trafficking and intracellular sequestration of GLUT4. To date, some of these proteins have been identified in fish (Díaz, M., and J. Planas, unpublished observations); however, their role in regulating fish GLUT4 trafficking has not yet been elucidated. The effect of cytochalasin B and indinavir on glucose uptake in the L6 cell lines suggests that btGLUT4 is less sensitive to these transport inhibitors due to differences in amino acid sequence and/or conformation of the inhibitor binding site. Therefore, these results support our hypothesis that differences in btGLUT4 amino acid sequence may affect its interaction with proteins that bind mammalian GLUT4 and are involved in GLUT4 traffic.
Overall, our data indicate that insulin-stimulated translocation of btGLUT4 to the plasma membrane occurs in L6 and brown trout skeletal muscle cells in culture, resulting in an enhanced glucose transport activity in these cells. Increased basal exocytosis of btGLUT4 to the cell surface and diffuse localization of intracellular btGLUT4 suggest that the traffic of btGLUT4 differs from that of rat-GLUT4, probably due to differences in certain amino acid motifs that affect the sorting and/or intracellular retention of btGLUT4 in the perinuclear region. Further investigations will be needed to elucidate the sequence signals in GLUT4 that determine the difference in the traffic characteristics of btGLUT4 in comparison with that of rat-GLUT4. From an evolutionary perspective, it is interesting that, although the response of GLUT4 to insulin appears to be well conserved between fish and mammals, mammalian GLUT4 appears to have improved its intracellular retention, in addition to its affinity for glucose. Therefore, btGLUT4 could represent a useful tool with which to further our understanding of the cellular mechanisms regulating GLUT4 traffic in mammalian cells.
| Acknowledgments |
|---|
| Footnotes |
|---|
Disclosure Statement: The authors of this manuscript have nothing to declare.
First Published Online August 16, 2007
1 M.D. and C.N.A. contributed equally to this work. ![]()
Abbreviations: btGLUT4, GLUT4-homolog in brown trout skeletal muscle; btGLUT4myc, overexpressing myc-tagged btGLUT4; 2-DG, 2-deoxy-D-[2,6-3H]glucose; FBS, fetal bovine serum; GLUT, glucose transporter; GS, goat serum; GSC, GLUT4 storage compartment; HA, hemagglutinin; HES, buffer of HEPES, sucrose, dithiothreitol, magnesium acetate, potassium acetate, and zinc chloride; HRP, horseradish peroxidase; okGLUT4, GLUT4-homolog in salmon adipose tissue; OPD, o-phenylenediamide; PFA, paraformaldehyde; PM, plasma membrane; TGN, trans-Golgi network.
Received February 26, 2007.
Accepted for publication August 9, 2007.
| References |
|---|
|
|
|---|
-ear-containing, Arf-binding protein adaptors mediate insulin-responsive trafficking of glucose transporter 4 in 3T3–L1 adipocytes. Mol Endocrinol 19:2145–2153This article has been cited by other articles:
![]() |
J. Castillo, D. Crespo, E. Capilla, M. Diaz, F. Chauvigne, J. Cerda, and J. V. Planas Evolutionary structural and functional conservation of an ortholog of the GLUT2 glucose transporter gene (SLC2A2) in zebrafish Am J Physiol Regulatory Integrative Comp Physiol, November 1, 2009; 297(5): R1570 - R1581. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Panserat, S. Skiba-Cassy, I. Seiliez, M. Lansard, E. Plagnes-Juan, C. Vachot, P. Aguirre, L. Larroquet, G. Chavernac, F. Medale, et al. Metformin improves postprandial glucose homeostasis in rainbow trout fed dietary carbohydrates: a link with the induction of hepatic lipogenic capacities? Am J Physiol Regulatory Integrative Comp Physiol, September 1, 2009; 297(3): R707 - R715. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Diaz, Y. Vraskou, J. Gutierrez, and J. V. Planas Expression of rainbow trout glucose transporters GLUT1 and GLUT4 during in vitro muscle cell differentiation and regulation by insulin and IGF-I Am J Physiol Regulatory Integrative Comp Physiol, March 1, 2009; 296(3): R794 - R800. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Plagnes-Juan, M. Lansard, I. Seiliez, F. Medale, G. Corraze, S. Kaushik, S. Panserat, and S. Skiba-Cassy Insulin regulates the expression of several metabolism-related genes in the liver and primary hepatocytes of rainbow trout (Oncorhynchus mykiss) J. Exp. Biol., August 1, 2008; 211(15): 2510 - 2518. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |